Studies showing inverse relationships between HLA-G expression and clinicopathological parameters associated with increased tumour burden showed prolonged survival or statistically non-significant poor clinical outcome associated with HLA-G expression [26,31,36]. The gene discussed is HLA-G; the disease is neoplasm.